SRTS

Sensus Healthcare

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 2

Sell signal 1

consensus rating "Strong Buy"

Revenue Beats Expectation

EPS Below Expectations

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About SRTS

Sensus Healthcare, Inc.

A medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions

Industry

Healthcare Equipment and Supplies

Established Date

05/07/2010

Listing Date

07/26/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.sensushealthcare.com

Security Type

Common stock

Office address

851 Broken Sound Pkwy., NW #215, Boca Raton, Florida 33487

Business

Introduction

Sensus Healthcare, Inc., a Delaware limited liability company, was formed on May 7, 2010. The company is a medical device company dedicated to providing highly effective, non-invasive, cost-effective treatments for both neoplastic and non-neoplastic skin conditions. Using a proprietary low-energy X-ray technology known as superficial radiation therapy (" SRT "), which is based on more than ten years of dedicated research and development, the company has successfully incorporated SRT into a portfolio of therapeutic devices: SRT-100TM, SRT-100 + TM and SRT-100 VisionTM. To date, SRT technology has been used to effectively and safely treat both neoplastic and non-neoplastic skin diseases in hundreds of thousands of patients worldwide.

Company Financials

EPS

SRTS has released its 2024 Q4 earnings. EPS was reported at 0.09, versus the expected 0.12, missing expectations. The chart below visualizes how SRTS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SRTS has released its 2024 Q4 earnings report, with revenue of 13.07M, reflecting a YoY change of 3.97%, and net profit of 1.55M, showing a YoY change of -63.28%. The Sankey diagram below clearly presents SRTS’s revenue sources and cost distribution.